Home/Stocks/Consumer Non-Cyclicals

Tate & Lyle PLC

TATE.L·Consumer Non-Cyclicals·Market Cap £2.5b
Rank #254 of 280
Quantitative Model · 280 Stocks Analysed
£5.59
+49.15% YTD
52W: £3.19 - £5.80

Factor Analysis Summary

Editorial assessment generated from Tate & Lyle PLC's live factor scores and sector positioning.

Based on Strategyland's proprietary 7-factor analysis, Tate & Lyle PLC (TATE.L) currently holds an overall rank of #254 out of 280 FTSE 100 constituents, reflecting its weighted composite score across liquidity, valuation, profitability, solvency, asset efficiency, market trading, and technical dimensions.

Key strengths include liquidity, where it demonstrates exceptional market liquidity with deep trading volumes that support efficient entry and exit, and technical (RSI 46.7), where it demonstrates positive technical momentum with price action supporting a constructive trend.

Areas requiring attention include profitability (ROE 5.6%, net margin 4.5%), where compressed margins and weak returns on equity weigh on the earnings profile, as well as solvency (debt/equity 0.8), where higher debt levels or weaker coverage ratios raise solvency concerns.

Within the Consumer Non-Cyclicals sector, Tate & Lyle PLC sits at composite rank #254, trailing the Consumer Non-Cyclicals peer average (rank 53). It ranks behind all 6 tracked Consumer Non-Cyclicals peers in our model.

Despite its mid-table composite rank of #254, Tate & Lyle PLC shows selective strength — notably in liquidity and technical — suggesting a stock with identifiable merits alongside clear areas for improvement.

Strongest Factors

  • Liquidity — Rank 30/280 (top quartile)
  • Technical — Rank 30/280 (top quartile)
  • Market Trading — Rank 140/280 (middle of the pack)

Weakest Factors

  • Profitability — Rank 251/280 (below average)
  • Solvency — Rank 213/280 (below average)

Score Analysis

Tate & Lyle PLC is ranked #254 out of 280 UK stocks. Lower factor scores indicate better performance in that category.

Factor Breakdown

139/280
Average Score
Liquidity
Excellent30/280
Valuation
Fair150/280
Profitability
Weak251/280
Solvency
Weak213/280
Asset Efficiency
Fair160/280
Mkt Trading
Fair140/280
Technical
Excellent30/280

1. Liquidity

Score: 30/280

How liquid is TATE and can it meet its short-term obligations?

0/6
liquidity criteria met
✗
Quick Ratio1.55x
Range: 0.8 - 1.3Rank 19/280
✗
Current Ratio2.71x
Range: 1.2 - 1.8Rank 51/280
✗
TTM Operating Cash Flow0.43x
Range: 0.8 - 1.5Rank 126/280
–
Liquidity Coverage RatioN/A
Range: N/A
✗
Intangible Asset Ratio0.07x
Range: 5 - 20Rank 65/280
✗
Cash-to-Debt Ratio0.27x
Range: 0.4 - 1.2Rank 131/280

Key Liquidity Metrics

Quick Ratio
1.55x
Sector: 0.8 - 1.3
Current Ratio
2.71x
Sector: 1.2 - 1.8

Overall Liquidity Rank

Rank within universe#30/280
Best (1)Worst (280)

2. Valuation

Score: 150/280

Is TATE undervalued compared to its peers and fair value metrics?

2/7
valuation criteria met
✗
FY27e P/E13.0x
Range: 15x - 28xRank 135/280
✗
FY26e P/E14.6x
Range: 15x - 28xRank 136/280
✓
FY27e Net Div Yld (%)3.59%
Range: 2.5 - 6.5Rank 116/280
✗
Div Payout Ratio97.75%
Range: 35 - 65Rank 25/280
✗
Current EV/EBITDA6.5x
Range: 8.0x - 13.0xRank 88/280
✓
Current P/TBV2.01x
Range: 1.5x - 4.5xRank 125/280
✗
Current P/B1.01x
Range: 1.5x - 4.5xRank 103/280

Key Valuation Metrics

TTM P/E
Price-to-Earnings
27.8x
FY26e P/E
Forward estimate
14.6x
FY27e P/E
Forward estimate
13.0x
Current P/B
Price-to-Book
1.01x
Current P/TBV
Tangible Book Value
2.01x
Current EV/EBITDA
Enterprise Value
6.5x
FY26e EV/EBITDA
Forward estimate
8.3x
FY27e EV/EBITDA
Forward estimate
8.7x

Dividend

TATE pays a dividend yield of 5.52%.

Current Yield
5.52%
FY27e Net Div Yield
3.59%
FY26e Gross DPS
0.198
FY27e Gross DPS
0.201

Dividend Per Share Forecast

3. Profitability

Score: 251/280

How profitable is TATE relative to its peers?

1/7
profitability criteria met
✗
TTM Profit Margin4.5%
Range: 5 - 11Rank 204/280
✗
T12 FCF Margin0.3%
Range: 8 - 15Rank 134/280
–
FY27e RoEN/A
Range: 8 - 20
✗
FY26 EPS Growth-6.8%
Range: 3 - 8Rank 198/280
✓
FY27e EPS Growth4.6%
Range: 4 - 8Rank 183/280
–
NIMN/A
Range: N/A
–
Expense RatioN/A
Range: 65 - 78
TTM Profit Margin
4.5%
Current RoCE
5.6%
FY27e RoE
N/A
T12 FCF Margin
0.3%

EPS Growth

4. Solvency

Score: 213/280

How strong is TATE's balance sheet and financial position?

0/6
solvency criteria met
✗
Debt/Eqt0.81x
Range: 0.3x - 0.7xRank 183/280
–
Interest Coverage RatioRank 185
Range: 4x - 10xRank 185/280
✗
Net Leverage Ratio2.14x
Range: 1.0x - 2.0xRank 132/280
–
Altman Z-Score (Manufacturing)3.27
Range: <1.10 - >2.60Rank 165/280
–
Z-Score (Non Manufacturing)Rank 197
Range: <1.10 - >2.60Rank 197/280
–
CapAdeq Ratio Tier1N/A
Range: N/A

Key Solvency Metrics

Debt/Eqt
0.81x
Net Leverage Ratio
2.14x
Interest Coverage
Rank 185
T12 FCF Margin
0.3%

Altman Z-Score

3.27
Safe Zone
01.812.995+

5. Asset Efficiency

Score: 160/280

How efficiently does TATE deploy its assets and intellectual capital?

1/5
asset efficiency criteria met
–
Efficiency RatioN/A
Range: N/A
✗
TTM Asset Turnover Ratio0.54x
Range: 0.8x - 1.5xRank 119/280
✗
TTM CAPEX/Sales6.2%
Range: 2 - 5Rank 72/280
✗
Working Capital Turnover2.63x
Range: 4x - 10xRank 118/280
✓
R&D/Sales FY27e3.0%
Range: 1.0 - 3.0Rank 27/280

Overall Asset Efficiency Rank

Rank within sector peers#160/280
Best (1)Worst (280)

6. Market Trading

Score: 140/280

How liquid and actively traded is TATE?

2/2
market trading criteria met
✓
Intraday Sentiment (%)56.0%
Range: 30 - 70Rank 108/280
–
10D-Avg v/s 3M-Avg Vol43%
Range: N/ARank 100/280
✓
Avg Directional Index 30D27.9
Range: 010 - 35Rank 51/280
–
Parabolic SAR561.00
Range: N/ARank 143/280
–
Stock Rating RankRank 50
Range: N/ARank 50/280
Market Cap
£2,488,748,376
Enterprise Value
£3,440,065,522

Trading Volume

7. Technical

Score: 30/280

What do the technical indicators say about TATE?

0/5
technical criteria met
–
CMP v/s 52-WH-3.6%
£5.80£3.19
-3.6%CMP: £5.59
Range: N/ARank 41/280
–
CMP v/s 52-WL75.0%
£5.80£3.19
+75.0%CMP: £5.59
Range: N/ARank 253/280
–
RSI 14D46.7
046.7 - Bearish100
Range: N/ARank 50/280
–
MA50 - MA200Bullish
£4.65+0.92£5.56
Range: N/ARank 53/280
–
MACD Rank-0.15
Golden Cross
MACD: -0.15
Range: N/A

RSI (14 Day)

46.7
Bearish
0 (Oversold)50100 (Overbought)

Moving Averages

50 SMA£5.56
200 SMA£4.65
SignalGolden Cross (Bullish)
MACD-0.15

Risk Metrics

Beta
N/A
3-Yr Std Dev
0.2%
5-Yr Std Dev
0.1%

Peer Comparison

How does TATE compare to other Consumer Non-Cyclicals stocks?

Overall Rank Comparison

Factor Score Comparison

StockRankLiquidityValuationProfitabilitySolvencyMkt TradingTechnical
TATE#2543015025121314030
ULVR.L#8131197141224108178
ANEA.L#23897815223152141
CCH.L#6111922615514170130
IMB.L#7117271110229107261
PRN.L#7484163274143268202
DGE.L#8148177162198137115
Sponsored
Healthcare Discovery Monitor
Live
Healthcare Discovery Monitor
Healthcare Discovery Monitorby StrategyLand

Catch Healthcare Events Before the Market Moves

SEC filings, FDA approvals, clinical trials, and regulatory events - scored for significance across 4 global markets.

10+
Sources
4
Markets
12h
Cycle
50+
Keywords
USUKCNEU
Launch Monitor

Methodology Note

The analysis presented for Tate & Lyle PLC is produced using Strategyland's proprietary 7-factor quantitative model, which evaluates each stock across Liquidity, Valuation, Profitability, Solvency, Asset Efficiency, Market Trading, and Technical dimensions. Individual factor scores and the composite rank reflect relative rankings within the FTSE 100 universe — a lower rank number indicates stronger performance in that category.

Underlying financial and market data is sourced from LSEG (London Stock Exchange Group) and processed through our scoring engine. Scores are recalculated as new data becomes available and should be interpreted as a systematic screening output, not a forecast of future share price performance.

This content is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance and factor rankings are not indicative of future results. Please read our Risk Disclaimer before making any investment decisions.

Note: The information provided is not intended as an offer or solicitation for the purchase or sale of any financial instruments but for investor relations purposes only. The aforementioned securities were offered to the public and currently trade on the secondary market at the exchange mentioned above. It is recommended that investors considering investing in any of these notes consult an approved MiFID Financial Advisor prior to investing.